Recent Finacing
Recent Raise
Pandion Therapeutics is a clinical-stage biotech developing modular biologics—IL-2 muteins, antibodies and bispecifics—that pair immunomodulators with tissue-selective tethers to deliver site-specific immune regulation for autoimmune and inflammatory diseases.
